Stock listing

Frankfurt:137 Aldeyra Therapeutics, Inc. Aktie

German listing (Frankfurt) of Aldeyra Therapeutics, Inc. · home listing NASDAQ:ALDX

Follow Aldeyra Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · FWB:137

€0.655 EUR +0.060 (+10.1%)

Close on Oct 20, 2026

Day range
€0.575 – €0.655 EUROct 20, 2026
Market cap
€39.51M EURAt the close on Oct 20, 2026 · price × 60.33M shares outstanding
Aldeyra Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ALDX · Home$0.734 USD+0.069 (+10.4%)1,635,185$0.654$0.748$0.650$0.665Close on Oct 20, 2026
Frankfurt:137€0.655 EUR+0.060 (+10.1%)—€0.585€0.655€0.575€0.595Close on Oct 20, 2026
Ticker
Frankfurt:137
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Aldeyra Therapeutics (NASDAQ:ALDX) Q2 2025 Earnings Call

    Tue, May 06, 2025 · 8:00 AM ET

    Watch Transcript
  • Aldeyra Therapeutics (NASDAQ:ALDX) Q4 2022 Earnings Call

    Thu, Mar 09, 2023 · 8:00 AM ET

    Watch Transcript
  • Aldeyra Therapeutics (NASDAQ:ALDX) Q3 2022 Earnings Call

    Thu, Nov 10, 2022 · 8:00 AM ET

    Watch Transcript

Latest news

All Aldeyra Therapeutics, Inc. news

Decks

Aldeyra Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
10 in the last 12 months · 162 in all · newest Sep 29, 2026 · oldest 2019
Calls
11 calls with a replay · 11 with a transcript · latest May 6, 2025
Decks
51 decks · latest Sep 29, 2026

Where Aldeyra Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ALDX · Home listingNASDAQUnited StatesUSD
BOATS:ALDXBOATSUnited StatesUSD
LS Exchange:A111X8LS ExchangeGermanyEUR
gettex:137gettexGermanyEUR
Lang & Schwarz:A111X8Lang & SchwarzGermanyEUR
Frankfurt:137 · This pageFrankfurtGermanyEUR
Tradegate:137TradegateGermanyEUR
Dusseldorf:137DusseldorfGermanyEUR
Munich:137MunichGermanyEUR
Stuttgart:137StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Aldeyra Therapeutics, Inc.